MIS-416

N/A

Report date: 2024/01/02 20:03:52

Base Information

Drug NameMIS-416
Drug Alias NameMIS 416MIS-416
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionNucleotide-binding oligomerization domain-containing protein 2 modulatorsToll-like receptor modulators
TargetsNucleotide-binding oligomerization domain-containing protein 2Toll-like receptor
Therapy Area/IndicationsMultiple Sclerosis, Chronic ProgressiveFallopian Tube NeoplasmsCarcinoma, Non-Small-Cell Lung +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNew ZealandAustralia
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInnate Immunotherapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRoswell Park Cancer InstituteInnate Immunotherapeutics Ltd
Active IndicationsN/A
Inactive IndicationsMultiple Sclerosis, Chronic ProgressiveFallopian Tube NeoplasmsCarcinoma, Non-Small-Cell Lung +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia